tiprankstipranks
Trending News
More News >
20 Microns Limited (IN:20MICRONS)
:20MICRONS
India Market
Advertisement

20 Microns Limited (20MICRONS) AI Stock Analysis

Compare
2 Followers

Top Page

IN:20MICRONS

20 Microns Limited

(20MICRONS)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 4o)
Rating:66Neutral
Price Target:
₹200.00
▲(4.36% Upside)
The overall stock score of 66 reflects strong financial performance and attractive valuation, offset by bearish technical indicators. The company's robust revenue and profit growth, along with a solid balance sheet, are significant strengths. However, challenges in cash flow management and negative market momentum weigh on the score. The stock's low P/E ratio suggests potential undervaluation, providing a positive outlook for long-term investors.
Positive Factors
Revenue Growth
Consistent revenue growth indicates robust demand for the company's products across various industries, supporting long-term business expansion.
Effective Cost Management
Effective cost management enhances profitability, allowing the company to reinvest in growth opportunities and maintain competitive pricing.
Strong Balance Sheet
A strong balance sheet with prudent leverage management provides financial stability and flexibility for future investments.
Negative Factors
Cash Flow Challenges
Negative free cash flow growth indicates potential liquidity issues, which could constrain the company's ability to fund operations and growth initiatives.
EBITDA Margin Concerns
A relatively low EBITDA margin compared to peers may indicate inefficiencies, affecting profitability and competitiveness in the long term.
Capital Expenditure Strain
High capital expenditures without corresponding cash inflows can strain financial resources, necessitating improved capital allocation strategies.

20 Microns Limited (20MICRONS) vs. iShares MSCI India ETF (INDA)

20 Microns Limited Business Overview & Revenue Model

Company Description20 Microns Limited engages in the industrial micronized minerals and specialty chemicals businesses in India. The company offers industrial minerals, such as ground calcium carbonate, dolomite, hydrous and calcined kaolins, talcs, natural barytes, silica/quartz, muscovite mica, feldspar/nepheline syenite, diatomaceous and siliceoaus earth, bentonite and attapulgite, and natural and synthetic red oxide. It also provides functional additives and specialties, including white/buff and colored, rutile TiO2, white pigment opacifiers, synthetic barium sulphate, micronized wax, anti-blocking additives, rheological additives, matting agents, inorganic thickeners, flame retardants, calcium oxide desiccant, activators for rubber, high aspect ratio talc, sub-micron CaCO3, and decorative colored quartz sand; erueca mide, olea mide, and processing aids; and fumed, precipitated, and amorphous silica. The company serves paints and coatings, inks and pigments, plastics and polymer, paper, rubber, cosmetics, ceramics, adhesive and sealant, oil-well drilling, agrochemicals, foundry, and other industries. It also exports its products. The company was incorporated in 1987 and is headquartered in Vadodara, India.
How the Company Makes Money20 Microns Limited generates revenue primarily through the sale of its industrial minerals and specialty chemicals to various industries including paints, coatings, plastics, rubber, and construction. The company's revenue model is based on direct sales to manufacturers and distributors, with a focus on long-term contracts that ensure steady cash flow. Key revenue streams include the sale of micronized minerals, which are critical for improving product performance in end-use applications. Additionally, the company benefits from strategic partnerships with other manufacturers and suppliers, which help expand its market reach and product offerings. By investing in research and development, 20MICRONS also creates value-added products that allow for premium pricing, further enhancing its profitability.

20 Microns Limited Financial Statement Overview

Summary
20 Microns Limited demonstrates strong financial performance with consistent revenue and profit growth, effective cost management, and operational efficiency. The balance sheet is solid with a strong equity position and manageable leverage. However, cash flow management poses challenges, with negative free cash flow growth and a need for more efficient capital allocation.
Income Statement
85
Very Positive
20 Microns Limited has shown strong revenue growth with a notable increase from the previous year, indicating a positive trajectory. The company has consistently improved its gross profit margin, reaching 46.97% in the most recent year. The EBIT margin is also robust at 38.78%, reflecting effective operational management. However, the EBITDA margin of 13.21% suggests potential areas for operational efficiency improvements. Overall, the income statement metrics highlight strong profitability and growth, though there's room for optimizing EBITDA.
Balance Sheet
78
Positive
The balance sheet of 20 Microns Limited is stable with a favorable debt-to-equity ratio of 0.39, indicating prudent leverage management. The return on equity (ROE) is impressive at 14.53%, showcasing effective use of equity capital. The equity ratio stands at 60.09%, highlighting a strong equity base relative to total assets. Despite these strengths, the company should remain vigilant about debt management to maintain financial stability.
Cash Flow
60
Neutral
The cash flow statement reveals some challenges, as the free cash flow has decreased significantly, resulting in negative free cash flow growth. The operating cash flow to net income ratio is 0.51, indicating moderate cash conversion from earnings. The free cash flow to net income ratio is negative due to substantial capital expenditures, suggesting the need for careful capital investment planning. Overall, while the operating cash flow remains positive, the cash flow position could be improved with more efficient capital allocation.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue9.30B9.17B7.76B7.02B6.11B4.83B
Gross Profit4.04B4.31B2.77B3.24B2.20B1.64B
EBITDA1.20B1.21B994.95M886.70M815.54M607.63M
Net Income613.75M623.76M560.70M418.19M345.85M229.72M
Balance Sheet
Total Assets0.007.15B5.90B4.60B5.15B4.52B
Cash, Cash Equivalents and Short-Term Investments312.98M393.96M606.82M299.41M168.49M40.62M
Total Debt0.001.66B1.22B1.08B1.23B1.04B
Total Liabilities-4.34B2.80B2.36B1.91B2.63B2.37B
Stockholders Equity4.34B4.29B3.53B2.94B2.51B2.14B
Cash Flow
Free Cash Flow0.00-448.94M345.62M507.09M79.27M415.86M
Operating Cash Flow0.00317.86M544.43M631.97M353.20M520.48M
Investing Cash Flow0.00-632.56M-204.69M-176.74M-231.72M-91.26M
Financing Cash Flow0.00140.21M-55.10M-379.73M-36.04M-452.65M

20 Microns Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price191.65
Price Trends
50DMA
208.37
Negative
100DMA
222.63
Negative
200DMA
215.90
Negative
Market Momentum
MACD
-5.45
Negative
RSI
39.19
Neutral
STOCH
59.32
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:20MICRONS, the sentiment is Negative. The current price of 191.65 is below the 20-day moving average (MA) of 198.00, below the 50-day MA of 208.37, and below the 200-day MA of 215.90, indicating a bearish trend. The MACD of -5.45 indicates Negative momentum. The RSI at 39.19 is Neutral, neither overbought nor oversold. The STOCH value of 59.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:20MICRONS.

20 Microns Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
₹12.74B19.070.50%28.67%50.12%
66
Neutral
₹7.62B12.420.65%7.23%5.00%
63
Neutral
₹8.17B21.100.41%12.35%6.79%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
58
Neutral
₹9.98B15.5767.43%
54
Neutral
₹6.27B44.130.12%13.17%-0.02%
52
Neutral
₹6.84B19.3015.56%2114.71%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:20MICRONS
20 Microns Limited
191.65
-51.25
-21.10%
IN:BODALCHEM
Bodal Chemicals Limited
54.01
-20.12
-27.14%
IN:INDOBORAX
Indo Borax & Chemicals Limited
242.75
45.68
23.18%
IN:KHAICHEM
Khaitan Chemicals & Fertilizers Ltd.
84.83
12.79
17.75%
IN:SHIVALIK
Shivalik Rasayan Ltd
398.75
-206.47
-34.11%
IN:SHREEPUSHK
Shree Pushkar Chemicals & Fertilisers Ltd.
399.75
49.76
14.22%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 25, 2025